Cargando…
Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype
BACKGROUND: Metaplastic breast cancer (MBC) is a rare and aggressive subtype of the breast. To understand the characteristics and prognosis of single hormone receptor-positive (HR+) MBC (estrogen receptor-positive [ER+]/progesterone receptor-negative [PR-] and ER-/PR+), we compared these tumors to d...
Autores principales: | Mao, Jinqian, Hu, Jin, Zhang, Yanting, Shen, Jian, Dong, Fang, Zhang, Ximeng, Ming, Jie, Huang, Tao, Run, Xiaoqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105402/ https://www.ncbi.nlm.nih.gov/pubmed/33972826 http://dx.doi.org/10.3389/fendo.2021.628939 |
Ejemplares similares
-
The Effect of HER2 Status on Metaplastic Breast Cancer A Propensity Score-Matched Analysis
por: Hu, Jin, et al.
Publicado: (2022) -
Metaplastic breast cancer: Treatment and prognosis by molecular subtype
por: Hu, Jin, et al.
Publicado: (2021) -
Presentation and survival by hormonal receptor status in metaplastic breast cancer: A propensity score-matched analysis
por: Wang, Siqin, et al.
Publicado: (2021) -
Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020) -
Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors
por: Djomehri, Sabra I., et al.
Publicado: (2020)